Takeda and Arcturus join hunt for coronavirus therapies

The Japanese drugs giant Takeda and the US biotech Arcturus Therapeutics have joined the hunt for therapies for the COVID-19 coronavirus.

Chinese biotech censured for misleading coronavirus drug cla...

China’s BrightGene Bio-Medical Technology has been censured by the Shanghai Stock Exchange for wrongly claiming it is able to manufacture Gilead’s experimental drug remdesivir – scientists’

GSK teams up with Clover on coronavirus vaccine

Moderna shares slide after record $604m US listing

RNA drug specialist Moderna smashed the record for an initial public offering (IPO) in the US on Friday, raising a whopping $604 million, although its shares retreated 19% after the debut.

Secretive Moderna could finally go public with $500m IPO

RNA medicine specialist Moderna is attempting the biggest IPO in biotech history, after applying to raise $500 million from investors.

Moderna and Merck expand partnership to develop new cancer v...

Moderna and Merck & Co have expanded their partnership to develop and commercialise novel personalised messenger RNA (mRNA) cancer vaccines.